Bleeding Disorders A-Z

Hemophilia Leadership Group Created

A select group of hemophilia community leaders visited the National Hemophilia Foundation (NHF) national offices in New York City in...

Adults & Aging, Hemophilia A&B, Advocacy, Community in Action

Throughout his life, Dan Bond has offered his time and body to the cause of science. The Galveston, Texas, engineer...

Hemophilia A&B, Rare Bleeding Disorders, Taking Charge

As Patrice Flax, MS, MSW, was chatting with the clerk at the checkout counter, she mentioned her appointment as education...

“Missense” and “nonsense” make sense at the molecular level. These are genetic mutations that cause hemophilia. Knowing your genotype, or...

Hemophilia A&B, Carriers

In late 2009, the US Food and Drug Administration (FDA) approved two new medications of interest to the bleeding disorders...

Learn more in this issue's cover article, " What's Your Genotype?"

Hemophilia A&B

Having von Willebrand disease (VWD) doesn’t hold Ray Pierce back. The 20-year-old junior at Catholic University of America in Washington...

A lot has changed in the more than 30 years since hemophilia treatment centers (HTCs) were started as a way...

Hemophilia A&B, Advocacy

Access ongoing clinical trials now.

Hemophilia A&B, Taking Charge

The National Hemophilia Foundation (NHF) is pleased to announce its research and fellowship award winners, who were honored at NHF’s...

Hemophilia A&B

In the 2008 New York City Marathon, runner #48068 was an architect from Alabama. He was also a liver transplant...

Hepatitis C, Surgery & Transplants

New research by scientists at the University of Michigan could lead to the development of drugs to combat HIV/AIDS in...

HIV